- Price is above Fair Value, showing premium demand versus the model.
ECILC
IST
Week ended 07 Aug 2026
Weekly Investor Report
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
69.50 TRY
2.2%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -26.1% below the Trend Line and sits at 26.0% of its 52-week range. The latest completed week returned 2.2%, after a -8.4% four-week move. The latest news-sentiment score is 50/100.
Setup score
28
out of 100
Latest Close
69.50 TRY
7 Aug 2026
1W Return
2.2%
latest completed week
4W Return
-8.4%
short-term follow-through
12W Return
-18.1%
quarterly tape
Trend Breadth
69.2%
36 of 52 weeks active
Volume Ratio
1.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.2%
Latest completed week; four-week move -8.4%.
Indicator stack
38/35
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -26.1% below the Trend Line and sits at 26.0% of its 52-week range. The latest completed week returned 2.2%, after a -8.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0412-week average 0.16
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.04Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -8.4% over four weeks, -18.1% over 12 weeks, and 38.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year36
Trend breadth69.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.97Latest activity-pressure read.
Pressure change25.3%Four-week change in activity pressure.
Leadership-28.43Latest relative-leadership reading.
RS change-17.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-46.5%Distance below the 52-week high.
13-week volatility4.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher8 of 2618 weeks finished lower.
Best week+16.7%Week of 13 Feb.
Worst week-17.2%Week of 17 Apr.
Latest week+2.2%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains3
Flat weeks0
Modest losses8
Sharp losses10
Recent vol4.3%13-week weekly-return volatility.
Base vol9.3%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew10.3% / -5.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTR Healthcare
4-week rank11 / 15
Group average-1.9%
Trend breadth40.0%
Trend40.0%active weekly trend signals
MD33.3%positive activity pressure
RS26.7%positive relative leadership
Four-week leaders
IndustryTR Drug Manufacturers - Specialty & Generic
4-week rank4 / 4
Group average-1.2%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD50.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape30/100
Trend, activity pressure, participation, and risk combine to a 30/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.04; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 69.50 TRY | 2.2% | 94.04 TRY | 59.80 TRY | -0.97 | -28.43 | 18.3M | Off |
| 31 Jul 2026 | 68.00 TRY | -4.3% | 94.70 TRY | 59.62 TRY | -1.06 | -28.21 | 13.3M | Off |
| 24 Jul 2026 | 71.05 TRY | -3.3% | 95.16 TRY | 59.44 TRY | -1.15 | -27.49 | 15.5M | Off |
| 17 Jul 2026 | 73.50 TRY | -3.2% | 95.48 TRY | 59.23 TRY | -1.27 | -25.04 | 12.6M | Off |
| 10 Jul 2026 | 75.90 TRY | -1.4% | 95.73 TRY | 59.01 TRY | -1.30 | -24.27 | 19.0M | Off |
| 3 Jul 2026 | 76.95 TRY | 0.9% | 96.01 TRY | 58.77 TRY | -1.36 | -23.51 | 2.8M | Off |
| 26 Jun 2026 | 76.30 TRY | -7.3% | 96.33 TRY | 58.51 TRY | -1.36 | -23.29 | 2.7M | Off |
| 19 Jun 2026 | 82.35 TRY | 3.1% | 96.81 TRY | 58.25 TRY | -1.32 | -19.59 | 2.9M | Off |
| 12 Jun 2026 | 79.90 TRY | -4.9% | 97.49 TRY | 57.92 TRY | -1.29 | -17.26 | 5.3M | Off |
| 5 Jun 2026 | 84.00 TRY | -5.5% | 97.81 TRY | 57.61 TRY | -1.20 | -11.16 | 3.0M | Off |
| 29 May 2026 | 88.90 TRY | 8.3% | 97.65 TRY | 57.26 TRY | -1.07 | -5.41 | 9.6M | Off |
| 22 May 2026 | 82.05 TRY | -3.3% | 97.65 TRY | 56.87 TRY | -1.08 | -13.25 | 19.9M | Off |
| 15 May 2026 | 84.85 TRY | -6.8% | 97.89 TRY | 56.50 TRY | -1.03 | -13.48 | 42.2M | Off |
| 8 May 2026 | 91.05 TRY | 8.8% | 98.36 TRY | 56.11 TRY | -1.00 | -11.15 | 54.7M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.